Long Term Follow-Up Study of the Safety and Exploratory Efficacy of Pneumostem in Premature Infants With Bronchopulmonary Dysplasia

Trial Profile

Long Term Follow-Up Study of the Safety and Exploratory Efficacy of Pneumostem in Premature Infants With Bronchopulmonary Dysplasia

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 26 May 2015

At a glance

  • Drugs Mesenchymal stem cell therapy (Primary)
  • Indications Bronchopulmonary dysplasia
  • Focus Adverse reactions
  • Sponsors Samsung Medical Center
  • Most Recent Events

    • 19 May 2015 Planned End Date changed from 1 Dec 2013 to 1 Sep 2017 as reported by ClinicalTrials.gov record.
    • 19 May 2015 Planned primary completion date changed from 1 Dec 2013 to 1 Sep 2017 as reported by ClinicalTrials.gov record.
    • 24 Sep 2014 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified July 2012)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top